Meridian Bioscience Obtains FDA Clearance For Legionella Test - Quick Facts

Trade VIVO now with

2/27/2012 1:07 PM ET

Meridian Bioscience Inc. (VIVO: Quote) announced that it has received clearance from the U.S. Food and Drug Administration for TRU Legionella, a new rapid assay for detection of legionellosis.

TRU Legionella is a rapid lateral flow device that provides optimized detection of Legionella pneumophila serogroup that is most commonly associated with Legionnaire's disease. Suspected infection is characterized by non-specific upper respiratory symptoms.

Click here to receive FREE breaking news email alerts for Meridian Bioscience Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 71 Articles

Editors Pick

Modest Gain In Eurozone PMI Revives Recovery Hopes

An indicator of Eurozone's private sector activity improved more than expected in May, renewing hopes that the economy is inching towards a recovery. Nonetheless, the indicator remained in negative territory, signaling sharp deterioration in overall business activity. The composite output index rose to a three-month high of 47.7 in May from 46.9 in April.

China Manufacturing Contracts As New Orders Slump

China's manufacturing sector contracted for the first time in seven months in May amid poor demand, fueling concerns that the weakness in the economy may persist for some more time. The headline purchasing managers' index, an indicator of the health of the factory sector, fell to a seven-month low of 49.6 in May from 50.4 in April. Readings below 50 indicate contraction of the sector.

HP Profit Falls Yet Tops Estimates

Hewlett-Packard Co. said Wednesday after the markets closed that its second quarter profit fell 32% from last year, hurt by lower revenue and weaker margins amid a slump in PC sales. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast.